Press release
Pharmacogenomics Market is Expanding with Genomic Testing Personalized Treatment and Drug Response Optimization | Key Players: Abbott Laboratories, Agilent Technologies Inc., Qiagen, and Thermo Fisher Scientific Inc., among others
Pharmacogenomics Market
The latest Pharmacogenomics Market Report by DataM Intelligence offers a clear analysis of global trends, market size, key players, and growth drivers. Covering emerging technologies, evolving care models, and regulatory insights, it provides strategic intelligence to help stakeholders navigate the dynamic healthcare landscape through 2025-2033
Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access):
https://www.datamintelligence.com/download-sample/pharmacogenomics-market?ophp
Pharmacogenomics studies how genetic variations affect individual responses to drugs, enabling more precise and effective treatment. The market is expanding rapidly with advancements in genomic sequencing, increasing demand for personalized medicine, and growing integration into oncology, psychiatry, and cardiovascular care protocols.
Pharmacogenomics Market Competitors Overview:
Abbott Laboratories, Agilent Technologies Inc., Becton, Dickinson and Company, Biomerieux, Bio-Rad Laboratories Inc., Illumina, Eurofins Scientific, Pacific Biosciences of California Inc., Qiagen, and Thermo Fisher Scientific Inc., among others.
Important Industry Updates of 2024 and 2025:
✅ In June 2025, UGenome AI, a pioneer in genomic software solutions, entered into a strategic partnership with PlexusDx, a rapidly growing molecular diagnostics company specializing in pharmacogenomic (PGx) and nutrigenomic (NGx) testing.
Pharmacogenomics Market Segments Overview:
∎ By Product and Service Type (Kits & Reagents, Instruments, Software & Services)
∎ By Technology (DNA Sequencing, Polymerase Chain Reaction (PCR), Microarray, Electrophoresis, Mass Spectrometry, Others)
∎ By Application (Drug Discovery, Personalized Medicine, Clinical Research, Others)
∎ By Disease Area (Oncology, Cardiovascular Disorders, Neurological Diseases, Infectious Diseases, Mental Health, Others)
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/pharmacogenomics-market?ophp
Methodology and Scope:
This Pharmacogenomics Market report is developed using a robust research methodology that combines primary interviews, insights from industry experts, and verified secondary sources such as company filings, trade journals, and trusted databases. It follows a bottom-up and top-down approach to ensure data accuracy through triangulation. The scope of the report covers current market trends, growth potential, and strategic developments across global and regional markets.
Regional Overview for Pharmacogenomics Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Looking For Exclusive Full Report? Get it here: https://www.datamintelligence.com/buy-now-page?report=pharmacogenomics-market?ophp
The Report Includes:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Go-to-market Strategy.
➡ Neutral perspective on the market performance.
➡ Customized regional/country reports as per request and country level analysis.
➡ Potential & niche segments and regions exhibiting promising growth covered.
People Also Ask:
➤ What are the global sales, production, import, and export trends in the Pharmacogenomics market?
➤ Who are the top manufacturers, and what are their output, pricing, and revenue figures?
➤ What key opportunities and challenges do vendors face in this market?
➤ Which product types, applications, or end-users are driving growth and holding market share?
➤ What are the main growth drivers and restraints affecting the Pharmacogenomics market?
Unlock 360° Market Intelligence with DataM Subscription Services:
https://www.datamintelligence.com/reports-subscription
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmacogenomics Market is Expanding with Genomic Testing Personalized Treatment and Drug Response Optimization | Key Players: Abbott Laboratories, Agilent Technologies Inc., Qiagen, and Thermo Fisher Scientific Inc., among others here
News-ID: 4104997 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
Waste Management Industry Set To Boom| Market Trends, Expansion & Leading Compan …
Market Size and Growth
Global Waste Management Market reached US$ 1.5 trillion in 2022 and is expected to reach US$ 1.9 trillion by 2030, growing with a CAGR of 3.0% during the forecast period 2024-2031.
DataM Intelligence has released its latest research, "Waste Management Market Size 2025," providing a detailed overview of the industry. The report offers a deep dive into key market drivers, regional growth, and the competitive landscape, equipping businesses…
Automotive Wet Friction Materials Market Poised for $3.7 Billion Growth by 2031, …
Global Automotive Wet Friction Materials Market is expected to reach US$ 3.70 billion by 2031, growing with a CAGR of 6.7% during the forecast period 2024-2031. This robust growth is propelled by advancements in automotive technologies, rising demand for efficient and durable friction materials, and stringent emission regulations fostering the use of energy-efficient systems.
Automotive Wet Friction Materials Market is positioned for robust growth, and shifting market dynamics reshaping the competitive…
Fuel Cell Market | Growth Drivers, Key Players, Market Trends & Global Investmen …
Market Size and Growth
Fuel Cell Market reached at a CAGR during the forecast period 2024-2031.
DataM Intelligence has released its latest research, "Fuel Cell Market Size 2025," providing a detailed overview of the industry. The report offers a deep dive into key market drivers, regional growth, and the competitive landscape, equipping businesses with the insights needed to navigate this dynamic sector.
Mergers and acquisition
✔ UK-based VivoPower signed a non-binding agreement to merge…
North America Microbiology Culture Market to hit US$ 16,092.48 million by 2033 | …
"The North America microbiology culture market reached US$ 9,247.82 million in 2024 and is expected to reach US$ 16,092.48 million by 2033, growing at a CAGR of 6.4% during the forecast period 2025-2033." As per DataM intelligence research report
North America Microbiology Culture Market: Recent Industry Developments
✅ In July 2025, BD (Becton, Dickinson and Company) launched its BD KiestraTM 3rd-Generation Total Lab Automation System in the U.S. and Canada.The platform streamlines…
More Releases for Pharmacogenomics
Pharmacogenomics - Top Companies Regional and Data Analysis
Pharmacogenomics is a branch of science, which studies the role of gene over the activity of a drugs and hence helps the refreshers in predicting the response of novel as well as previously available therapies.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007564/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Pharmacogenomics Market are:
• F. Hoffmann-la Roche Ltd
• Abbott
• Oxford Nanopore Technologies
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• QIAGEN
• Agilent Technologies, Inc.
• Myriad Genetics, Inc.
• Admera Health
Contact Us:
If you have any queries about…
Pharmacogenomics Market worth $5.8 billion by 2028
North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising rate of cancer has contributed to growth of the pharmacogenomics market.
Pharmacogenomics Market [https://www.marketsandmarkets.com/Market-Reports/pharmacogenomics-market-142682251.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR of 10.6% from 2023 to…
Genetic Medicine: Unveiling the Power of Pharmacogenomics
Based on technology, the pharmacogenomics market is segmented into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. The market for the PCR segment is subsegmented into real time PCR, standard PCR, and digital PCR. The PCR segment dominated the pharmacogenomics market in 2021 and is expected to register the highest CAGR during the forecast period.
Download Sample PDF Details at: https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10776
The pharmacogenomics market is segmented on the basis of…
Complete PDF Guide On Pharmacogenomics [PDF]
According to our latest study on "Pharmacogenoics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Technology, Application, and End User," the market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their…
Global Pharmacogenomics Market Size & Trends
According to a new market research report published by Global Market Estimates, the global pharmacogenomics market is projected to grow at a CAGR of 9.6% from 2023 to 2028.
The growth of the global pharmacogenomics market is driven by advancements in genomics and DNA sequencing technologies, the rising demand for personalized medicine, regulatory support from agencies like the FDA, cost-effectiveness through reduced adverse reactions, and a growing aging population with complex…
Global Pharmacogenomics Services Market Insights | 2022-2032
The Pharmacogenomics Services Market refers to the services provided by companies and laboratories that offer personalized medicine based on a patient's genetic makeup. Pharmacogenomics is the study of how an individual's genes affect their response to certain drugs, and the pharmacogenomics services market focuses on utilizing this knowledge to optimize drug therapy.
These services typically involve genetic testing to identify specific genetic variations that may impact a patient's response to certain…
